The SPAC and New Issue ETF (SPCX) Launches on NYSE

The SPAC and New Issue ETF starts trading on the NYSE today under SPCX. It is the first actively-managed exchange traded fund that gives investors direct exposure to the disruptive capital markets theme of SPACs.

“The SPAC market has traditionally been hard to access for all but a small group of institutional investors,” said Matthew Tuttle, Chief Executive Officer and Chief Investment Officer of Tuttle Tactical Management, which serves as the advisor to SPCX. “As there is limited information on publicly-traded SPACs, selecting the right SPAC in which to invest can seem like a daunting task. SPCX offers investors a broad portfolio of SPACs within the familiar liquid and tax-efficient wrapper of an ETF.”

Through Dec. 8, there have been 217 SPAC IPOs this year, with gross proceeds exceeding $74 billion. That compares to 59 SPAC IPOs in 2019 representing $13.6 billion. Read more.

Total
0
Shares
Related Posts
Read More

Bellevue Life Sciences Reschedules Extension Vote 

Bellevue wants six more months up to Nov. 14 to complete its deal with OSR Holdings, a global healthcare holding company. If the proposal passes, Bellevue’s sponsor would deposit $50,000 into traust for each month requied up to the new deadlines.
Read More

Osisko Green Acquisition Files Preliminary Prospectus for $250M IPO

Osisko Green intends to focus its search for businesses or assets involved in the shift away from fossil fuels to green energy and related industries and commodities such as mining of battery minerals, refining and processing, technology and supply chains, with an aggregate enterprise value of between $500 million and $1 billion.